A Comparative Study on the Influence of Zirconia and Titanium Nanoparticles on the Functionality of Osteocytes In Vitro
Open Access
- 1 January 2026
- journal article
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1) , 6486868
Abstract
Introduction and Aim: The aim of this study was to compare the influence of zirconia dioxide nanoparticles (ZrO 2 ‐NPs) and titanium dioxide nanoparticles (TiO 2 ‐NPs) on the functionality of osteocytes in vitro. Methods: MLO‐Y4 osteocytic cells were treated with varying concentrations of ZrO 2 ‐NPs or TiO 2 ‐NPs for viability studies. Apoptosis assays following treatment with 100 and 500 µg/mL of ZrO 2 ‐NPs or TiO 2 ‐NPs for 72 h were performed. Sclerostin (SOST) levels were assessed at 24 and 72 h, while receptor activator of nuclear factor kappa‐B ligand (RANKL) and osteoprotegerin (OPG) were measured at 72 h by ELISA and real‐time PCR analysis. Results: Viability assays revealed a dose‐dependent cytotoxicity for both types of nanoparticles, with TiO 2 ‐NPs reducing cell viability at 100 µg/mL within 24 h, while ZrO 2 ‐NPs promoted proliferation at lower concentrations but showed similar cytotoxicity at higher doses. Apoptosis and necrosis assays revealed a dose‐dependent cytotoxic response, with TiO 2 ‐NPs inducing significant cell death at 100 µg/mL, while ZrO 2 NPs showed minimal effects at the same concentration; at 500 µg/mL, both nanoparticles markedly increased apoptosis, with TiO 2 ‐NPs eliciting higher apoptosis. SOST gene expression and SOST release were significantly enhanced following exposure to both ZrO 2 ‐NPs and TiO 2 ‐NPs, with TiO 2 ‐NPs inducing significantly higher levels. TiO 2 ‐NPs upregulated RANKL while downregulating OPG both at the gene and protein levels. Although ZrO 2 ‐NPs exhibited a similar trend, their impact on SOST expression, RANKL, and OPG release was notably lower, suggesting a potentially less disruptive impact on bone remodeling. Conclusion: The findings offer valuable insights into the osteocyte‐mediated effects of implant‐related nanoparticles. ZrO 2 ‐NPs are a less disruptive alternative to TiO 2 ‐NPs for bone implants, offering insights into osteocyte‐mediated remodeling and guiding biomaterial selection for implant longevity.Keywords
This publication has 36 references indexed in Scilit:
- Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathwaysActa Biomaterialia, 2019
- Zirconia Nanoparticles-Induced Toxic Effects in Osteoblast-Like 3T3-E1 CellsDiscover Nano, 2018
- TiO2, SiO2 and ZrO2 Nanoparticles Synergistically Provoke Cellular Oxidative Damage in Freshwater MicroalgaeNanomaterials, 2018
- The effect of metal ions released from different dental implant-abutment couples on osteoblast function and secretion of bone resorbing mediatorsJournal of Dentistry, 2017
- Osseointegration of titanium, titanium alloy and zirconia dental implants: current knowledge and open questionsPeriodontology 2000, 2016
- Zirconia in biomedical applicationsExpert Review of Medical Devices, 2016
- Engineered nanoparticles induce cell apoptosis: potential for cancer therapyOncotarget, 2016
- Five-year success rate of 831 consecutively placed Zirconia dental implants in humans: a comparison of three different rough surfaces.2010
- Allocation of nonbirefringent wear debris: Darkfield illumination associated with PIXE microanalysis reveals cobalt deposition in mineralized bone matrix adjacent to CoCr implantsJournal of Biomedical Materials Research Part A, 2008
- Establishment of an Osteocyte-like Cell Line, MLO-Y4Journal of Bone and Mineral Research, 1997